The patients received an additional targeted amount of 400 mg/d eicosapentaenoic acid and docosahexaenoic acid , 2 g/d - linolenic acid , eicosapentaenoic acid-docosahexaenoic acid plus - linolenic acid , or placebo for 40 months .